NASDAQ : RCEL
AVITA Medical, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 16.71 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 516.79M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 484.01M |
| Enterprise Value | 521.35M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 30.93M |
| Shares Outstanding | 30.93M |
| Shares Change (YoY) | +14.29% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 1.50% |
| Owned by Institutions (%) | 16.41% |
| Float | 30.46M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.40 |
| Forward PS | 4.81 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 6.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.41 |
| Quick Ratio | 0.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.45 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -41.56% |
| Return on Invested Capital (ROIC) | -84.11% |
| Return on Capital Employed (ROCE) | 168.20% |
| Weighted Average Cost of Capital (WACC) | 15.10% |
| Revenue Per Employee | $334,650 |
| Profits Per Employee | -$190,628 |
| Employee Count | 226 |
| Asset Turnover | 1.43 |
| Inventory Turnover | 2.18 |
Taxes
| Measure | Value |
|---|
| Income Tax | 21,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.01 |
| 52-Week Price Change | +324.12% |
| 50-Day Moving Average | 12.21 |
| 200-Day Moving Average | 6.55 |
| Relative Strength Index (RSI) | 66.15 |
| Average Volume (20 Days) | 419,912 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.84M |
| Short Previous Month | 2.89M |
| Short % of Shares Out | 9.26% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 8.36 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 75.63M |
| Gross Profit | 61.68M |
| Operating Income | -35.22M |
| Pretax Income | -43.06M |
| Net Income | -43.08M |
| EBITDA | -32.76M |
| EBIT | -35.22M |
| Loss Per Share | -$1.44 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 11.14M |
| Total Debt | 48.48M |
| Net Cash | -37.35M |
| Net Cash Per Share | -$1.21 |
| Equity (Book Value) | -27.84M |
| Book Value Per Share | -0.90 |
| Working Capital | -40.32M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -24.23M |
| Capital Expenditures | -387,000 |
| Depreciation & Amortization | 2.45M |
| Net Borrowing | 6.10M |
| Free Cash Flow | -24.61M |
| FCF Per Share | -$0.80 |
Margins
| Measure | Value |
|---|
| Gross Margin | 81.56% |
| Operating Margin | -46.56% |
| Pretax Margin | -56.94% |
| Profit Margin | -56.96% |
| EBITDA Margin | -43.32% |
| EBIT Margin | -46.56% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -14.29% |
| Shareholder Yield | n/a |
| Earnings Yield | -9.18% |
| FCF Yield | -5.09% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $13.57 |
| Price Target Difference | -13.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 22.51% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jun 30, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -13.31 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |